NZ509215A - Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels - Google Patents

Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels

Info

Publication number
NZ509215A
NZ509215A NZ509215A NZ50921599A NZ509215A NZ 509215 A NZ509215 A NZ 509215A NZ 509215 A NZ509215 A NZ 509215A NZ 50921599 A NZ50921599 A NZ 50921599A NZ 509215 A NZ509215 A NZ 509215A
Authority
NZ
New Zealand
Prior art keywords
blood serum
lipid levels
serum lipid
preparation containing
active ingredient
Prior art date
Application number
NZ509215A
Inventor
Achim Berthold
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NZ509215A publication Critical patent/NZ509215A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

A preparation containing at least one active substance inhibiting hydroxymethylglutaryl-CoA reductase, which influences blood serum lipid levels of an organism, wherein the preparation is in the form of a transdermal therapeutic plaster containing the above active substance in a self-adhesive matrix layer which is located on the side opposite the skin and which can be covered by a backing layer that is impermeable to the active substance is disclosed.
NZ509215A 1998-07-09 1999-07-07 Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels NZ509215A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (en) 1998-07-09 1998-07-09 Composition containing at least one substance influencing blood lipid levels and its use
PCT/EP1999/004757 WO2000002541A1 (en) 1998-07-09 1999-07-07 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Publications (1)

Publication Number Publication Date
NZ509215A true NZ509215A (en) 2003-04-29

Family

ID=7873488

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ509215A NZ509215A (en) 1998-07-09 1999-07-07 Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels

Country Status (22)

Country Link
EP (1) EP1094797B1 (en)
JP (1) JP2002520272A (en)
KR (1) KR100549848B1 (en)
CN (1) CN1309377C (en)
AR (1) AR019902A1 (en)
AT (1) ATE278395T1 (en)
AU (1) AU770573B2 (en)
BR (1) BR9911941A (en)
CA (1) CA2336712C (en)
CZ (1) CZ300976B6 (en)
DE (2) DE19830732B4 (en)
ES (1) ES2230872T3 (en)
HU (1) HU226614B1 (en)
IL (2) IL140667A0 (en)
MX (1) MXPA01000126A (en)
NZ (1) NZ509215A (en)
PL (1) PL194983B1 (en)
RU (1) RU2227023C2 (en)
TR (1) TR200100021T2 (en)
TW (1) TWI237572B (en)
WO (1) WO2000002541A1 (en)
ZA (1) ZA200100171B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (en) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparation for protecting plants against diseases
JP4630065B2 (en) * 2002-09-20 2011-02-09 興和株式会社 Topical preparation
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006515026A (en) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド Pharmaceutical preparations for the treatment of breast diseases and disorders
KR20060135826A (en) * 2004-03-31 2006-12-29 코와 가부시키가이샤 External preparation
EP1611882B1 (en) 2004-06-01 2010-04-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4986411B2 (en) * 2004-06-01 2012-07-25 久光製薬株式会社 Patch
WO2006002127A1 (en) * 2004-06-21 2006-01-05 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
DE102004062182B4 (en) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient
JP2009529051A (en) * 2006-03-07 2009-08-13 オステオスクリーン アイピー， エルエルシー Bone and cartilage strengthening by HMGCo-A reductase inhibitors
KR100817274B1 (en) * 2006-08-21 2008-03-27 삼성전기주식회사 Light emitting diode package and method of manufacturing the same
EP3556359A4 (en) 2016-12-19 2020-08-05 Nutritape, S.L. Energising patch for sportspeople
EP3938076A1 (en) * 2019-03-12 2022-01-19 Corning Incorporated Ceramic honeycomb body with skin
TWI803052B (en) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 Transdermal delivery device, methods of using and making the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (en) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (en) * 1994-04-29 1995-11-03 Lafon Labor New galenic form for transdermal administration.
AU3618795A (en) * 1994-10-05 1996-05-02 Hisamitsu Pharmaceutical Co., Inc. Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation
DE19541260A1 (en) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutic preparation for transdermal application of active ingredients through the skin
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Also Published As

Publication number Publication date
HU226614B1 (en) 2009-04-28
TWI237572B (en) 2005-08-11
PL194983B1 (en) 2007-07-31
KR100549848B1 (en) 2006-02-06
MXPA01000126A (en) 2002-06-04
CA2336712C (en) 2008-09-09
AR019902A1 (en) 2002-03-20
CZ200193A3 (en) 2001-05-16
CZ300976B6 (en) 2009-09-30
CN1309377C (en) 2007-04-11
HUP0102718A2 (en) 2002-03-28
IL140667A (en) 2007-05-15
AU770573B2 (en) 2004-02-26
AU5157499A (en) 2000-02-01
BR9911941A (en) 2001-03-27
IL140667A0 (en) 2002-02-10
PL345510A1 (en) 2001-12-17
DE59910758D1 (en) 2004-11-11
CN1308525A (en) 2001-08-15
DE19830732A1 (en) 2000-01-13
ES2230872T3 (en) 2005-05-01
WO2000002541A1 (en) 2000-01-20
ATE278395T1 (en) 2004-10-15
EP1094797A1 (en) 2001-05-02
CA2336712A1 (en) 2000-01-20
HUP0102718A3 (en) 2002-12-28
EP1094797B1 (en) 2004-10-06
ZA200100171B (en) 2001-08-10
KR20010079513A (en) 2001-08-22
DE19830732B4 (en) 2008-11-13
TR200100021T2 (en) 2001-05-21
RU2227023C2 (en) 2004-04-20
JP2002520272A (en) 2002-07-09

Similar Documents

Publication Publication Date Title
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
DE3584766D1 (en) TRANSDERMAL SYSTEM FOR TIMOLOL.
MY100066A (en) Multicompartmentalized dermal and transdermal patches.
PL335446A1 (en) Transcutaneous therapeutic system
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
SI1009393T1 (en) Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
DE69916492D1 (en) PLASTER FOR THE TRANSDERMAL APPLICATION OF VOLATILE, LIQUID ACTIVE SUBSTANCES
ATE109357T1 (en) TRANSDERMAL ESTRADIOL AS A THERAPEUTIC SYSTEM.
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
AU4739089A (en) Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
NO20000894L (en) Transdermal therapeutic system with active substance of Scopolamine base
NZ502405A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
AU715763B2 (en) Surface-stabilised pharmaceutical preparation for skin application
IL114948A (en) Transdermal therapeutic system containing estradiol and process for the preparation thereof
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
ES1004874U (en) Improved therapeutic taping. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired